The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

BACKGROUND: The aim of this study was to evaluate the efficacy and safety of CapeOX plus bevacizumab with a planned oxaliplatin stop-and-go strategy in Japanese patients with metastatic colorectal cancer (mCRC). METHODS: Patients with untreated mCRC were treated with 4 cycles of CapeOX plus bevacizu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Cancer
Main Authors: Nakayama, Goro, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Uehara, Keisuke, Kojima, Hiroshi, Ishiyama, Akiharu, Hayashi, Naomi, Takano, Nao, Hattori, Norifumi, Kobayashi, Daisuke, Tanaka, Chie, Hayashi, Masamichi, Kanda, Mitsuro, Yamada, Suguru, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Fujii, Tsutomu, Murotani, Kenta, Ando, Yuichi, Kodera, Yasuhiro
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2017
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379705/
https://ncbi.nlm.nih.gov/pubmed/28376737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3245-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים